Keywords: Vifor, Fresenius, PA21, FDA, USA, EMA, hypeeeerphosphaaatemia, Dialisis patients

Vifor Fresenius PA21 filed for approval with US FDA, accepted by EMA

Article | 11 February 2013

Print This

A New Drug Application for PA21 (iron(III)-oxyhydroxide) has been submitted to the US Food and Drug Administration. Separately, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in